Connect with us

Cannabis

ArgenCann Will Be Part of Expo Cannabis 2021

With little more than a year of creation, the Argentine Chamber of Cannabis marked a milestone for the rapid growth achieved as an institution and the positioning reached, being a benchmark in the cannabis agro-industrial sector currently; an emerging industry worldwide that seeks to consolidate in Argentina due to its competitive advantages, technical quality and agro-exporting capacity.

Published

on

The Argentine Chamber of Cannabis (ArgenCann), an entity that brings together more than 120 members, including companies, enterprises, and professionals related to the cannabis industry, will be present at Expo Cannabis 2021, the most important event on medical, industrial, and adult-use cannabis in Latin America.

During October 15th, 16th, and 17th at La Rural, ArgenCann will have its own space so that all those interested can learn more about the industry and the activity it has been developing in pursuit of a regulatory framework in our country. There, they will seek to receive all local stakeholders to tell them about all the initiatives promoted by the Chamber with the aim of building and developing the national cannabis industry.

In addition, on Friday, October 15th, Pablo Fazio, president of ArgenCann, will speak from 11:30 am at the B2B business event organized by Expo Cannabis. That same day, at 6 p.m., a panel for companies will be held at the chamber’s stand to discuss the cannabis production chain. The talk will be given by three members of ArgenCann: Paula Lanzelotti, Technical Director of Laboratorio Melacrom, together with Milton Cordone of AppChem and Fernando Ferrante of F&C Green Labs.

“It is really important for our organization to be part of this Cannabis Expo. It will be our first opportunity to present ourselves in society in an event of this magnitude. We are convinced that it will be a good platform to make contact with many entrepreneurs and businessmen of the sector to invite them to be part of our work agenda, convinced of all the potential that the cannabis industry has to propose to our country in terms of investment, production and job creation,” says Pablo Fazio, President of the Argentine Chamber of Cannabis.

SEE ALSO  German crowdfunding platform comes to the rescue of local businesses

Read more on the subject and find the latest hemp news with the hemp.im mobile app.

A historic first year for the cannabis industry in Argentina

With little more than a year of creation, the Argentine Chamber of Cannabis marked a milestone for the rapid growth achieved as an institution and the positioning reached, being a benchmark in the cannabis agro-industrial sector currently; an emerging industry worldwide that seeks to consolidate in Argentina due to its competitive advantages, technical quality and agro-exporting capacity.

The joint work carried out from ArgenCann led to gather today more than 120 members and to create strategic alliances with associations from Brazil, Colombia, Chile, Ecuador, Mexico, Paraguay, Peru, and Uruguay; besides being founding members and presiding the nascent American Network of Cannabis Associations (RedCann).

The Chamber continues to support all government initiatives in favor of the development of the activity, and in search of the rapid granting of licenses, registrations, and registrations to enable the work of entrepreneurs in the sector.

In turn, ArgenCann participates in training and debates for the benefit of the whole community. It recently presented the First National Cannabis Survey, a study carried out among more than 1,518 people together with 80 doctors and pharmacists from all over the country, who gave their opinion on the different uses of cannabis, both at a medicinal and industrial level, as well as for responsible adult consumption, with a significant level of acceptance at all levels.

__

(Featured image by Julianza via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in El Economista, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Anthony Donaghue writes about science and technology. Keeping abreast of the latest tech developments in various sectors, he has a keen interest on startups, especially inside and outside of Silicon Valley. From time to time, he also covers agritech and biotech, as well as consumer electronics, IT, AI, and fintech, among others. He has also written about IPOs, cannabis, and investing.

Continue Reading